MENU
IMNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immunome (IMNM) Earnings Date & Reports
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies... Show more
A.I. Advisor
published Earnings
IMNM is expected to report earnings to rise 7.29% to -51 cents per share on August 19
Q2'26
Est.
$-0.51
Q1'26
Beat
by $0.07
Q4'25
Missed
by $0.18
Q3'25
Missed
by $0.08
Q2'25
Beat
by $0.12
The last earnings report on May 12 showed earnings per share of -47 cents, beating the estimate of -55 cents. With 324.74K shares outstanding, the current market capitalization sits at 2.17B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 425 939-7410
Employees
177
Web
https://www.immunome.com